After receiving approval from the institutional ethics committee, one patient will be selected per day by simple random sampling from total number of major surgeries posted the day. Major surgeries are defined as surgeries whose duration is likely to exceed two hours. Written informed consent will be obtained from the patient after sharing the information about the study. 10 Pre-operative baseline trans thoracic echo (apical 4 chamber view) will be performed in left lateral position on the selected patient using Sonosite Xporte ultrasound machine with P21xp (1-5MHz) cardiac probe in the preoperative holding area to record the base line Echo parameters quantifying left ventricular systolic function (ejection fraction) and diastolic function (E, A, E/A, Septal/lateral e/, E/e/, LA Volume index, TR velocity). If the patient has poor echo-cardiographic window in left lateral position, ECHO will be repeated in supine position and subsequent measurements for the patient would be taken in the same position( left lateral/ supine) where good echo cardiographic window is obtained. If the patient has left ventricular systolic dysfunction or if the echo cardiographic window continuous to be poor, the patient will be excluded from the study. Another patient from study population will be selected as per the detailed procedure described above for inclusion in the study. To maintain accuracy in measurements, all transthoracic-echo parameters will be recorded by both the investigator and the echo-cardiographer until the time the investigator recorded values are consistent with echo-cardiographer values. After recording the baseline parameters, the patient will be shifted into operating theatre and standard monitoring will be established with SPO2, ECG, NIBP/IBP, EtCO2, temperature and urine output measurement. The anaesthetic technique will be as per the decision of the attending anaesthesiologist. All the TTE measurements will be done in left lateral position/ supine position (position in which baseline recordings are done) as per the description below. 1. If the choice is TIVA (Total intravenous anaesthesia) with propofol, the measurement will be done one minute after induction. 11 2. If the choice is inhalational anaesthesia, the measurement will be done after obtaining steady state 1 MAC anaesthesia with Isoflurane/sevoflurane /Desflurane. 3. If the choice is intravenous induction followed by inhalational anaesthesia, one measurement will be done one minute after intravenous induction with propofol and second measurement after obtaining steady state 1 MAC anaesthesia with Isoflurane/sevoflurane /Desflurane. 4. If the choice is regional anaesthesia combined with general anaesthesia, the measurement will be taken after establishing both. 5. If the choice is spinal, the measurement will be taken 10 minutes after spinal. 6. If the choice is epidural, the measurement will be taken 20 minutes after epidural. 7. If the choice is peripheral nerve block, the measurement is taken after establishing complete block. During intermittent positive ventilation, measurement will be taken during expiratory phase, if necessary by prolonging it, by not initiating the next breath. During anaesthesia, the SpO2, ECG, NIBP, EtCO2 and temperature will be monitored continuously. Care will be taken to maintain fluid balance and blood will be replaced as per requirement. The temperature will be maintained above 36*C all the time, if needed by active warming methods. Normocarbia will be maintained by adjusting ventilation under general anaesthesia. Hypoxemia will be prevented by administering O2 by mask for the patients under regional anaesthesia. Blood pressure will be maintained within 20% of baseline by using appropriate methods. Hourly urine output will be monitored |